Olema Pharmaceuticals (OLMA) Cash from Operations (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Cash from Operations data on file, last reported at 45987000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 4.57% year-over-year to 45987000.0 in Q1 2026; TTM through Mar 2026 was 148724000.0, a 19.14% decrease from a year earlier, with the FY2025 full-year figure at 146716000.0, down 40.6% from the prior year.
• Cash from Operations for Q1 2026 stood at 45987000.0, down from 38327000.0 in the prior quarter.
• Over the last five years, Cash from Operations for OLMA reached as high as 17903000.0 in Q1 2022 and fell as low as 45987000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 27226235.29 across 5 years, with a median of 26284000.0 in 2024.
• Across the five-year window, Cash from Operations tumbled 197.13% in 2022 and climbed 16.41% in 2023, its largest moves.
• Year by year, Cash from Operations stood at 19711000.0 in 2022, then gained by 6.27% to 18476000.0 in 2023, then tumbled by 42.26% to 26284000.0 in 2024, then slumped by 45.82% to 38327000.0 in 2025, then dropped by 19.99% to 45987000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 45987000.0 in Q1 2026, 38327000.0 in Q4 2025, and 34527000.0 in Q3 2025.